Wall Street Analysts Think Leidos (LDOS) Is a Good Investment: Is It?

The article evaluates the utility of Wall Street analyst recommendations (Average Brokerage Recommendation - ABR) against the Zacks Rank, using Leidos (LDOS) as a case study. While LDOS holds a Buy-equivalent ABR of 1.88, the piece cautions against relying solely on ABRs due to inherent positive biases within brokerage firms. Instead, it emphasizes the Zacks Rank, a quantitative model driven by earnings estimate revisions, as a more reliable indicator for near-term price performance. For LDOS, a recent 0.8% increase in the current year's Zacks Consensus EPS estimate to $10.74 has resulted in a Zacks Rank #2 (Buy), suggesting a legitimate basis for potential near-term stock appreciation.

Analysis

The investment case for Leidos (LDOS) is supported by a confluence of positive sell-side sentiment and favorable earnings estimate revisions. The stock currently holds an Average Brokerage Recommendation (ABR) of 1.88 on a 1-5 scale, positioning it between a 'Buy' and 'Strong Buy'. This consensus is based on ratings from 16 brokerage firms, of which nine (56.3%) rate the stock as a 'Strong Buy'. While the article cautions against the inherent optimistic bias in such sell-side ratings, it highlights a more tangible quantitative signal: the Zacks Consensus Estimate for current-year earnings per share has increased by 0.8% over the last month to $10.74. This upward revision by analysts is presented as a primary driver for a potential near-term price increase and is the basis for the stock's Zacks Rank #2 (Buy), suggesting that the positive analyst sentiment is underpinned by improving fundamental expectations.

Key Decisions for Investors

• Investors with an existing bullish thesis on Leidos may find confirmation in the alignment between the strong sell-side consensus and the positive trajectory of earnings estimate revisions.
• Monitor future earnings estimate revisions for LDOS closely, as this is identified as a more reliable and timely indicator of near-term price performance than the static Average Brokerage Recommendation.
• Given the noted systemic positive bias in sell-side ratings, it is prudent to weigh the 0.8% upward revision in the consensus EPS estimate to $10.74 more heavily than the ABR when conducting due diligence.